Skip to content
DataLookout
Menu

NCT06796894

Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved 5 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words Show 4 more changesShow less
    • Primary completion pushed from Oct 30, 2026 to Mar 30, 2027
    • Study completion pushed from Dec 1, 2026 to Apr 1, 2027
    • Secondary endpoints: details revised at 5 of 9 entries
    • Study description revised
  2. Notable Primary completion date: Oct 30, 2025 to Oct 30, 2026
    • Study completion date: Dec 1, 2025 to Dec 1, 2026
    v4
  3. Notable Primary completion date: Mar 30, 2025 to Oct 30, 2025
    • Study completion date: Apr 1, 2025 to Dec 1, 2025
    v3
  4. Notable Primary endpoints: 2 to 1
    • Primary completion date: Feb 27, 2025 to Mar 30, 2025
    • Secondary endpoints expanded, about 28 words
    v2
  5. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Respiratory Symptoms
Timeframe: One day

Secondary (9)

Pulmonary functions
Dyspnea during daily life
Asthma Control Level
Fatigue level
Asthma and allergic rhinit symptoms
Show 4 moreShow less
Activities of daily living
Frailty
Disease spesific quality of life
Laboratory testing

Sites

1 site in 1 country

  • Hacettepe UniversityAnkara, State, Turkey (Türkiye)